| Product Code: ETC7549464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Oncogene Inhibitors Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Oncogene Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 India Oncogene Inhibitors Market - Industry Life Cycle |
3.4 India Oncogene Inhibitors Market - Porter's Five Forces |
3.5 India Oncogene Inhibitors Market Revenues & Volume Share, By Genes, 2021 & 2031F |
3.6 India Oncogene Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Oncogene Inhibitors Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 India Oncogene Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Oncogene Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Oncogene Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Oncogene Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing adoption of targeted therapies for cancer treatment |
4.2.3 Rise in research and development activities in oncology sector |
4.3 Market Restraints |
4.3.1 High cost of oncogene inhibitors |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited access to advanced cancer treatments in certain regions of India |
5 India Oncogene Inhibitors Market Trends |
6 India Oncogene Inhibitors Market, By Types |
6.1 India Oncogene Inhibitors Market, By Genes |
6.1.1 Overview and Analysis |
6.1.2 India Oncogene Inhibitors Market Revenues & Volume, By Genes, 2021- 2031F |
6.1.3 India Oncogene Inhibitors Market Revenues & Volume, By EGFR, 2021- 2031F |
6.1.4 India Oncogene Inhibitors Market Revenues & Volume, By HER, 2021- 2031F |
6.1.5 India Oncogene Inhibitors Market Revenues & Volume, By BRCA, 2021- 2031F |
6.1.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Oncogene Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Oncogene Inhibitors Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 India Oncogene Inhibitors Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.4 India Oncogene Inhibitors Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.5 India Oncogene Inhibitors Market Revenues & Volume, By Pancreas Cancer, 2021- 2031F |
6.2.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Oncogene Inhibitors Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 India Oncogene Inhibitors Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021- 2031F |
6.3.3 India Oncogene Inhibitors Market Revenues & Volume, By PARP Inhibitors, 2021- 2031F |
6.3.4 India Oncogene Inhibitors Market Revenues & Volume, By Anti-HER Antibodies, 2021- 2031F |
6.3.5 India Oncogene Inhibitors Market Revenues & Volume, By EFGR Inhibitors, 2021- 2031F |
6.3.6 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Oncogene Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Oncogene Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Oncogene Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 India Oncogene Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Oncogene Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Oncogene Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Oncogene Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Oncogene Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Oncogene Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 India Oncogene Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 India Oncogene Inhibitors Market Import-Export Trade Statistics |
7.1 India Oncogene Inhibitors Market Export to Major Countries |
7.2 India Oncogene Inhibitors Market Imports from Major Countries |
8 India Oncogene Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials using oncogene inhibitors in India |
8.2 Adoption rate of personalized medicine in cancer treatment |
8.3 Investment in oncology research and development in India |
9 India Oncogene Inhibitors Market - Opportunity Assessment |
9.1 India Oncogene Inhibitors Market Opportunity Assessment, By Genes, 2021 & 2031F |
9.2 India Oncogene Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Oncogene Inhibitors Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 India Oncogene Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Oncogene Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Oncogene Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Oncogene Inhibitors Market - Competitive Landscape |
10.1 India Oncogene Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 India Oncogene Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here